Anti-DNase B: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Added additional categories
sources
Line 1: Line 1:
Anti-Deoxyribonuclease B (Anti-DNase B) titers are a quantitative measure of serologic antibodies obtained from patients suspected of having a recent group A (Beta-hemolytic) strep infection aka Streptococcus Pyogenes. In a patient with suspected post-streptococcal glomerulonephritis anti-streptolysin-O aka ASO titers can be negative even after strep pharyngitis. Some studies suggest that up to 85% of patients with acute rheumatic fever from group A strep infection will be positive for ASO titers, leaving 15% of patients having been diagnosed with rheumatic fever negative for ASO titers. In addition and contrary to percentages seen in strep pharyngitis, strep skin infection induces ASO antibodies less often, which can be problematic for physicians searching for a cause of the glomerulonephritis and having a high suspicion that its etiology was strep. Post-streptococcus glomerulonephritis is more often associated with group A strep skin infection than it is with strep pharyngitis, so in a patient with suspected post-strep glomerulonephritis with a negative ASO titer, one can then obtain Anti-DNase-B titers which are more sensitive for group A strep and for its various strains. Anti-DNase B antibody titers also stay elevated for longer, which is useful since often ASO titers may rise, but then fall prior to the onset of the glomerulonephritis where the onset of disease is often greater than 2 weeks after the infection resolved. In this way anti-DNase B titers are very useful to clinicians and allow for evidence of the recent infection to be seen and levels of this antibody to be quantified.
Anti-Deoxyribonuclease B (Anti-DNase B) titres are a quantitative measure of the presence of serologic [[Antibody|antibodies]] obtained from patients suspected of having a recent group A (Beta-hemolytic) [[streptococcus]] bacteria infection, from ''[[Streptococcus pyogenes]]''.<ref name="UCSF Medical">{{cite web|title=Medical tests: Anti-Dnase B|url=https://www.ucsfhealth.org/tests/003537.html|publisher=[[UCSF Medical Center]]|accessdate=29 August 2016}}</ref><ref name="The Human Immune Response to Streptococcal Extracellular Antigens: Clinical, Diagnostic, and Potential Pathogenetic Implications">{{cite journal|last1=Johnson|first1=Dwight R.|last2=Kurlan|first2=Roger|last3=Leckman|first3=James|last4=Kaplan|first4=Edward L.|title=The Human Immune Response to Streptococcal Extracellular Antigens: Clinical, Diagnostic, and Potential Pathogenetic Implications|journal=Clinical Infectious Diseases|date=15 February 2010|volume=50|issue=4|pages=481–490|doi=10.1086/650167}}</ref>
In a patient with suspected post-streptococcal glomerulonephritis anti-streptolysin-O, titres can be negative even after strep pharyngitis. Some studies suggest that up to 85% of patients with acute rheumatic fever from group A strep infection will be positive for ASO titers, leaving 15% of patients having been diagnosed with rheumatic fever negative for ASO titers. In addition and contrary to percentages seen in strep pharyngitis, strep skin infection induces ASO antibodies less often, which can be problematic for physicians searching for a cause of the glomerulonephritis and having a high suspicion that its etiology was strep. Post-streptococcus glomerulonephritis is more often associated with group A strep skin infection than it is with strep pharyngitis, so in a patient with suspected post-strep glomerulonephritis with a negative ASO titer, one can then obtain Anti-DNase-B titers which are more sensitive for group A strep and for its various strains. Anti-DNase B antibody titers also stay elevated for longer, which is useful since often ASO titers may rise, but then fall prior to the onset of the glomerulonephritis where the onset of disease is often greater than 2 weeks after the infection resolved. In this way anti-DNase B titers are very useful to clinicians and allow for evidence of the recent infection to be seen and levels of this antibody to be quantified.
[[Anti-streptolysin_O|anti-streptolysin- O]]
[[Anti-streptolysin_O|anti-streptolysin- O]]
<ref>Antistreptolysin O and Anti-Deoxyribonuclease B Titers: Normal Values for Children Ages 2 to 12 in the United States Edward L. Kaplan, Constance D. Rothermel, Dwight R. Johnson Pediatrics Jan 1998, 101 (1) 86-88; DOI:</ref>
<ref>Antistreptolysin O and Anti-Deoxyribonuclease B Titers: Normal Values for Children Ages 2 to 12 in the United States Edward L. Kaplan, Constance D. Rothermel, Dwight R. Johnson Pediatrics Jan 1998, 101 (1) 86-88; DOI:</ref>

Revision as of 13:16, 29 August 2016

Anti-Deoxyribonuclease B (Anti-DNase B) titres are a quantitative measure of the presence of serologic antibodies obtained from patients suspected of having a recent group A (Beta-hemolytic) streptococcus bacteria infection, from Streptococcus pyogenes.[1][2]

In a patient with suspected post-streptococcal glomerulonephritis anti-streptolysin-O, titres can be negative even after strep pharyngitis. Some studies suggest that up to 85% of patients with acute rheumatic fever from group A strep infection will be positive for ASO titers, leaving 15% of patients having been diagnosed with rheumatic fever negative for ASO titers. In addition and contrary to percentages seen in strep pharyngitis, strep skin infection induces ASO antibodies less often, which can be problematic for physicians searching for a cause of the glomerulonephritis and having a high suspicion that its etiology was strep. Post-streptococcus glomerulonephritis is more often associated with group A strep skin infection than it is with strep pharyngitis, so in a patient with suspected post-strep glomerulonephritis with a negative ASO titer, one can then obtain Anti-DNase-B titers which are more sensitive for group A strep and for its various strains. Anti-DNase B antibody titers also stay elevated for longer, which is useful since often ASO titers may rise, but then fall prior to the onset of the glomerulonephritis where the onset of disease is often greater than 2 weeks after the infection resolved. In this way anti-DNase B titers are very useful to clinicians and allow for evidence of the recent infection to be seen and levels of this antibody to be quantified. anti-streptolysin- O [3] [4] [5]

References

  1. ^ "Medical tests: Anti-Dnase B". UCSF Medical Center. Retrieved 29 August 2016.
  2. ^ Johnson, Dwight R.; Kurlan, Roger; Leckman, James; Kaplan, Edward L. (15 February 2010). "The Human Immune Response to Streptococcal Extracellular Antigens: Clinical, Diagnostic, and Potential Pathogenetic Implications". Clinical Infectious Diseases. 50 (4): 481–490. doi:10.1086/650167. {{cite journal}}: no-break space character in |first1= at position 7 (help); no-break space character in |first4= at position 7 (help)
  3. ^ Antistreptolysin O and Anti-Deoxyribonuclease B Titers: Normal Values for Children Ages 2 to 12 in the United States Edward L. Kaplan, Constance D. Rothermel, Dwight R. Johnson Pediatrics Jan 1998, 101 (1) 86-88; DOI:
  4. ^ The paradox of the antibody response to streptodornase Wannamaker, Lewis W. The American Journal of Medicine , Volume 27 , Issue 4 , 567 - 574
  5. ^ Arch Dis Child. 2001 Sep;85(3):223-7. Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever. Carapetis JR1, Currie BJ.